Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY3023414 in recurrent or persistent endometrial cancer
NCT02549989Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 2015
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of samotolisib in endometrial cancer (EC), sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 2015; status: completed.
02
Drugs
samotolisib
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT02549989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549989.